Atlas Trials

The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism

Clinical trial NCT02111473 · COMPLETED

Trial details

NCT number
NCT02111473
Sponsor
Gulhane School of Medicine
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hypogonadism
Start date
2009-05-01
Primary completion
2012-05-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.